{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:31:40Z","timestamp":1778041900183,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06378-1","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:19:11Z","timestamp":1774531151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hemigland cryoablation versus high-intensity focused ultrasound for localized prostate cancer: a propensity-weighted comparison of functional and oncologic outcomes"],"prefix":"10.1007","volume":"44","author":[{"given":"Umberto","family":"Anceschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Misuraca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"D\u2019Annunzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo Maria","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Prata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Spadaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaconsiglia","family":"Ferriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Lugnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"key":"6378_CR1","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1089\/end.2018.0130","volume":"32","author":"S Albisinni","year":"2018","unstructured":"Albisinni S, M\u00e9lot C, Aoun F et al (2018) Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data. J Endourol 32:797\u2013804. https:\/\/doi.org\/10.1089\/end.2018.0130","journal-title":"J Endourol"},{"key":"6378_CR2","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/JU.0000000000001787","volume":"206","author":"A Stabile","year":"2021","unstructured":"Stabile A, Sanchez-Salas R, Tourinho-Barbosa R et al (2021) Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy. J Urol 206:638\u2013645. https:\/\/doi.org\/10.1097\/JU.0000000000001787","journal-title":"J Urol"},{"key":"6378_CR3","doi-asserted-by":"publisher","DOI":"10.1089\/end.2016.0830","author":"KJ Tay","year":"2017","unstructured":"Tay KJ, Polascik TJ, Elshafei A et al (2017) J Endourol 31:564\u2013571. https:\/\/doi.org\/10.1089\/end.2016.0830. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data"},{"key":"6378_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/JU.0000000000001327","volume":"205","author":"RC Borges","year":"2021","unstructured":"Borges RC, Tourinho-Barbosa RR, Glina S et al (2021) Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence. J Urol 205:129\u2013136. https:\/\/doi.org\/10.1097\/JU.0000000000001327","journal-title":"J Urol"},{"key":"6378_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/J.EURURO.2021.08.005","volume":"81","author":"JS Hopstaken","year":"2022","unstructured":"Hopstaken JS, Bomers JGR, Sedelaar MJP et al (2022) An Updated Systematic Review on Focal Therapy in Localized Prostate Cancer: What Has Changed over the Past 5 Years? Eur Urol 81:5\u201333. https:\/\/doi.org\/10.1016\/J.EURURO.2021.08.005","journal-title":"Eur Urol"},{"key":"6378_CR6","doi-asserted-by":"publisher","first-page":"3390JPM14121163","DOI":"10.3390\/JPM14121163","volume":"10","author":"CH Yang","year":"2024","unstructured":"Yang CH, Barbulescu DV, Marian L et al (2024) High-Intensity Focus Ultrasound Ablation in Prostate Cancer: A Systematic Review. J Pers Med 10:3390JPM14121163 https:\/\/doi.org\/10.3390\/JPM14121163","journal-title":"J Pers Med"},{"key":"6378_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41391-020-00315-y","volume":"24","author":"TT Shah","year":"2021","unstructured":"Shah TT, Reddy D, Peters M et al (2021) Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study. Prostate Cancer Prostatic Dis 24:567\u2013574. https:\/\/doi.org\/10.1038\/s41391-020-00315-y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6378_CR8","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.prnil.2022.12.001","volume":"11","author":"G Jung","year":"2023","unstructured":"Jung G, Kim JK, Oh JJ et al (2023) Partial gland ablation using high-intensity focused ultrasound versus robot-assisted radical prostatectomy: a propensity score-matched study. Prostate Int 11:134\u2013138. https:\/\/doi.org\/10.1016\/j.prnil.2022.12.001","journal-title":"Prostate Int"},{"key":"6378_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1089\/end.2019.0613","volume":"34","author":"PM Huber","year":"2020","unstructured":"Huber PM, Afzal N, Arya M et al (2020) An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer. J Endourol 34:641\u2013646. https:\/\/doi.org\/10.1089\/end.2019.0613","journal-title":"J Endourol"},{"key":"6378_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/BCO2.70065","author":"M Kaneko","year":"2025","unstructured":"Kaneko M, Ramacciotti LS, Inoue Y et al (2025) Impact of magnetic resonance imaging visibility of prostate cancer on partial gland ablation. BJUI compass. https:\/\/doi.org\/10.1002\/BCO2.70065","journal-title":"BJUI compass"},{"key":"6378_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.4081\/aiua.2022.4.413","volume":"94","author":"N Dias","year":"2022","unstructured":"Dias N, Rodriguez-Sanchez L, Colandrea G et al (2022) Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience. Arch Ital di Urol e Androl 94:413\u2013419. https:\/\/doi.org\/10.4081\/aiua.2022.4.413","journal-title":"Arch Ital di Urol e Androl"},{"key":"6378_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.eururo.2023.06.013","volume":"84","author":"S Deivasigamani","year":"2023","unstructured":"Deivasigamani S, Kotamarti S, Rastinehad AR et al (2023) Primary Whole-gland Ablation for the Treatment of Clinically Localized Prostate Cancer: A Focal Therapy Society Best Practice Statement. Eur Urol 84:547\u2013560. https:\/\/doi.org\/10.1016\/j.eururo.2023.06.013","journal-title":"Eur Urol"},{"key":"6378_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/JPM13060978","author":"L Misuraca","year":"2023","unstructured":"Misuraca L, Lugnani F, Brassetti A et al (2023) Single-Setting 3D MRI\/US-Guided Frozen Sectioning and Cryoablation of the Index Lesion: Mid-Term Oncologic and Functional Outcomes from a Pilot Study. J Pers Med. https:\/\/doi.org\/10.3390\/JPM13060978","journal-title":"J Pers Med"},{"key":"6378_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/ATM-21-5033","volume":"11","author":"S Kotamarti","year":"2023","unstructured":"Kotamarti S, Polascik TJ (2023) Focal cryotherapy for prostate cancer: a contemporary literature review. Ann Transl Med 11:26\u201326. https:\/\/doi.org\/10.21037\/ATM-21-5033","journal-title":"Ann Transl Med"},{"key":"6378_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ECI.14192","author":"S Ladjevardi","year":"2024","unstructured":"Ladjevardi S, Ebner A, Femic A et al (2024) Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study. Eur J Clin Invest. https:\/\/doi.org\/10.1111\/ECI.14192","journal-title":"Eur J Clin Invest"},{"key":"6378_CR16","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.purol.2023.09.012","volume":"33","author":"C Debard","year":"2023","unstructured":"Debard C, Margue G, Klein C et al (2023) Oncological and functional results of focal treatment of localized prostate cancer with HIFU. Prog en Urol 33:966\u2013973. https:\/\/doi.org\/10.1016\/j.purol.2023.09.012","journal-title":"Prog en Urol"},{"key":"6378_CR17","doi-asserted-by":"publisher","first-page":"501869","DOI":"10.1016\/j.acuroe.2025.501869","volume":"49","author":"K Eskandar","year":"2025","unstructured":"Eskandar K (2025) FocalONE high-intensity focused ultrasound for localized prostate cancer: A systematic review of oncologic outcomes, functional preservation, and technological evolution. Actas Urol Esp 49:501869. https:\/\/doi.org\/10.1016\/j.acuroe.2025.501869","journal-title":"Actas Urol Esp"},{"key":"6378_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.06.007","author":"K Shee","year":"2025","unstructured":"Shee K, Pace WA, Liu AW et al (2025) Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2025.06.007","journal-title":"Eur Urol Focus"},{"key":"6378_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","volume":"4","author":"D Mitropoulos","year":"2018","unstructured":"Mitropoulos D, Artibani W, Biyani CS et al (2018) Validation of the Clavien\u2013Dindo Grading System in Urology by the European Association of Urology Guidelines Ad Hoc Panel. Eur Urol Focus 4:608\u2013613. https:\/\/doi.org\/10.1016\/j.euf.2017.02.014","journal-title":"Eur Urol Focus"},{"key":"6378_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1089\/end.2018.0809","volume":"33","author":"A Bakavicius","year":"2019","unstructured":"Bakavicius A, Sanchez-Salas R, Muttin F et al (2019) Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized Methodology. J Endourol 33:509\u2013515. https:\/\/doi.org\/10.1089\/end.2018.0809","journal-title":"J Endourol"},{"key":"6378_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00345-018-2363-y","volume":"37","author":"KJ Tay","year":"2019","unstructured":"Tay KJ, Amin MB, Ghai S et al (2019) Surveillance after prostate focal therapy. World J Urol 37:397\u2013407. https:\/\/doi.org\/10.1007\/s00345-018-2363-y","journal-title":"World J Urol"},{"key":"6378_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41391-023-00699-7","volume":"27","author":"R Nicoletti","year":"2024","unstructured":"Nicoletti R, Alberti A, Castellani D et al (2024) Oncological results and cancer control definition in focal therapy for Prostate Cancer: a systematic review. Prostate Cancer Prostatic Dis 27:623\u2013634. https:\/\/doi.org\/10.1038\/s41391-023-00699-7","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6378_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005010.PUB3","author":"JH Jung","year":"2018","unstructured":"Jung JH, Risk MC, Goldfarb R et al (2018) Primary cryotherapy for localised or locally advanced prostate cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005010.PUB3. 2018:","journal-title":"Cochrane Database Syst Rev"},{"key":"6378_CR24","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1016\/j.clgc.2017.10.009","volume":"16","author":"A Elshafei","year":"2018","unstructured":"Elshafei A, Tay KJ, Kara O et al (2018) Associations Between Prostate Volume and Oncologic Outcomes in Men Undergoing Focal Cryoablation of the Prostate. Clin Genitourin Cancer 16:e477\u2013e482. https:\/\/doi.org\/10.1016\/j.clgc.2017.10.009","journal-title":"Clin Genitourin Cancer"},{"key":"6378_CR25","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1002\/SIM.7084","volume":"35","author":"PC Austin","year":"2016","unstructured":"Austin PC (2016) Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med 35:5642\u20135655. https:\/\/doi.org\/10.1002\/SIM.7084","journal-title":"Stat Med"},{"key":"6378_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111338","author":"F Bettega","year":"2024","unstructured":"Bettega F, Mendelson M, Leyrat C, Bailly S (2024) Use and reporting of inverse-probability-of-treatment weighting for multicategory treatments in medical research: a systematic review. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/j.jclinepi.2024.111338","journal-title":"J Clin Epidemiol"},{"key":"6378_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/SIM.9969","volume":"43","author":"EE Gabriel","year":"2024","unstructured":"Gabriel EE, Sachs MC, Martinussen T et al (2024) Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation. Stat Med 43:534\u2013547. https:\/\/doi.org\/10.1002\/SIM.9969","journal-title":"Stat Med"},{"key":"6378_CR28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/J.EUF.2021.04.008","volume":"8","author":"G Marra","year":"2022","unstructured":"Marra G, Soeterik T, Oreggia D et al (2022) Long-term Outcomes of Focal Cryotherapy for Low- to Intermediate-risk Prostate Cancer: Results and Matched Pair Analysis with Active Surveillance. Eur Urol Focus 8:701\u2013709. https:\/\/doi.org\/10.1016\/J.EUF.2021.04.008","journal-title":"Eur Urol Focus"},{"key":"6378_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/sim.70009","author":"PC Austin","year":"2025","unstructured":"Austin PC, Fine JP (2025) Inverse Probability of Treatment Weighting Using the Propensity Score With Competing Risks in Survival Analysis. Stat Med. https:\/\/doi.org\/10.1002\/sim.70009","journal-title":"Stat Med"},{"key":"6378_CR30","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1177\/0962280215584401","volume":"26","author":"PC Austin","year":"2017","unstructured":"Austin PC, Stuart EA (2017) The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes. Stat Methods Med Res 26:1654\u20131670. https:\/\/doi.org\/10.1177\/0962280215584401","journal-title":"Stat Methods Med Res"},{"key":"6378_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/S1677-5538.IBJU.2021.0091","volume":"48","author":"A Bakavicius","year":"2022","unstructured":"Bakavicius A, Marra G, Macek P et al (2022) Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol 48:263\u2013274. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2021.0091","journal-title":"Int Braz J Urol"},{"key":"6378_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/S41391-018-0042-0","volume":"21","author":"R Ganzer","year":"2018","unstructured":"Ganzer R, Arthanareeswaran VKA, Ahmed HU et al (2018) Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement. Prostate Cancer Prostatic Dis 21:175\u2013186. https:\/\/doi.org\/10.1038\/S41391-018-0042-0","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6378_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE et al (2017) New and Established Technology in Focal Ablation of the Prostate: A Systematic Review [figure presented]. Eur Urol 71:17\u201334. https:\/\/doi.org\/10.1016\/j.eururo.2016.08.044","journal-title":"Eur Urol"},{"key":"6378_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/JU.0000000000000506","volume":"203","author":"RR Tourinho-Barbosa","year":"2020","unstructured":"Tourinho-Barbosa RR, Sanchez-Salas R, Claros OR et al (2020) Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience. J Urol 203:320\u2013328. https:\/\/doi.org\/10.1097\/JU.0000000000000506","journal-title":"J Urol"},{"key":"6378_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/J.EUO.2025.02.003","author":"A \u015alusarczyk","year":"2025","unstructured":"\u015alusarczyk A, Gurwin A, Barna\u015b A et al (2025) Outcomes of Focal Therapy for Localized Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/J.EUO.2025.02.003","journal-title":"Eur Urol Oncol"},{"key":"6378_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/aja202159","volume":"24","author":"QM Yuan","year":"2022","unstructured":"Yuan QM, Lin TH, Jin K et al (2022) The comparison of survival between active surveillance or watchful waiting and focal therapy for low-risk prostate cancer: a real-world study from the SEER database. Asian J Androl 24:305\u2013310. https:\/\/doi.org\/10.4103\/aja202159","journal-title":"Asian J Androl"},{"key":"6378_CR37","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/S41391-023-00698-8","volume":"27","author":"R Nicoletti","year":"2024","unstructured":"Nicoletti R, Alberti A, Castellani D et al (2024) Functional outcomes and safety of focal therapy for prostate cancer: a systematic review on results and patient-reported outcome measures (PROMs). Prostate Cancer Prostatic Dis 27:614\u2013622. https:\/\/doi.org\/10.1038\/S41391-023-00698-8","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6378_CR38","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/pros.24600","volume":"83","author":"S Deivasigamani","year":"2023","unstructured":"Deivasigamani S, Orabi H, El-Shafei A et al (2023) Intermediate-term oncological and functional outcomes of salvage cryotherapy for the management of prostate cancer recurrence after primary brachytherapy versus primary cryotherapy: A propensity score-matched analysis. Prostate 83:1373\u20131386. https:\/\/doi.org\/10.1002\/pros.24600","journal-title":"Prostate"},{"key":"6378_CR39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/J.EUROS.2023.02.003","volume":"50","author":"A Ghoreifi","year":"2023","unstructured":"Ghoreifi A, Kaneko M, Peretsman S et al (2023) Patient-reported Satisfaction and Regret Following Focal Therapy for Prostate Cancer: A Prospective Multicenter Evaluation. Eur Urol open Sci 50:10\u201316. https:\/\/doi.org\/10.1016\/J.EUROS.2023.02.003","journal-title":"Eur Urol open Sci"},{"key":"6378_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102101","author":"ZLP Guang","year":"2024","unstructured":"Guang ZLP, Kristensen G, R\u00f8der A, Brasso K (2024) Oncological and Functional Outcomes of Whole-Gland HIFU as the Primary Treatment for Localized Prostate Cancer: A Systematic Review. Clin Genitourin Cancer. https:\/\/doi.org\/10.1016\/j.clgc.2024.102101","journal-title":"Clin Genitourin Cancer"},{"key":"6378_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/S41443-020-00357-9","volume":"33","author":"G Fallara","year":"2021","unstructured":"Fallara G, Capogrosso P, Maggio P et al (2021) Erectile function after focal therapy for localized prostate cancer: a systematic review. Int J Impot Res 33:418\u2013427. https:\/\/doi.org\/10.1038\/S41443-020-00357-9","journal-title":"Int J Impot Res"},{"key":"6378_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.juro.2017.08.076","volume":"199","author":"S Garcia-Barreras","year":"2018","unstructured":"Garcia-Barreras S, Sanchez-Salas R, Sivaraman A et al (2018) Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes. J Urol 199:140\u2013146. https:\/\/doi.org\/10.1016\/j.juro.2017.08.076","journal-title":"J Urol"},{"key":"6378_CR43","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/JU.0000000000001934","volume":"206","author":"A Rompr\u00e9-Brodeur","year":"2021","unstructured":"Rompr\u00e9-Brodeur A, Marcq G, Tholomier C et al (2021) Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer. J Urol 206:1177\u20131183. https:\/\/doi.org\/10.1097\/JU.0000000000001934","journal-title":"J Urol"},{"key":"6378_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41391-022-00501-0","volume":"26","author":"JR Heard","year":"2023","unstructured":"Heard JR, Naser-Tavakolian A, Nazmifar M, Ahdoot M (2023) Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes. Prostate Cancer Prostatic Dis 26:218\u2013227. https:\/\/doi.org\/10.1038\/s41391-022-00501-0","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6378_CR45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1159\/000521882","volume":"106","author":"A Borkowetz","year":"2022","unstructured":"Borkowetz A, Blana A, B\u00f6hmer D et al (2022) German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy. Urol Int 106:431\u2013439. https:\/\/doi.org\/10.1159\/000521882","journal-title":"Urol Int"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06378-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06378-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:19:12Z","timestamp":1774531152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06378-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6378"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06378-1","relation":{"references":[{"id-type":"doi","id":"10.1089\/end.2016.0830","asserted-by":"subject"}]},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Drs. Umberto Anceschi, Salvatore Basile, Leonardo Misuraca, Riccardo Mastroianni, Simone D\u2019Annunzio, Flavia Proietti, Alfredo Maria Bove, Francesco Prata, Mariaconsiglia Ferriero, Prof. Franco Lugnani, and Prof. Giuseppe Simone; and Mr. Riccardo Capecchi and Mr. Giuseppe Spadaro report no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of the IRCCS Regina Elena National Cancer Institute. Patient consent was waived due to the retrospective design and complete anonymization of data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"269"}}